Polysorbate 80

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

15 Listed Products, 1 Nanjing Bold Chemical, 1 Nanjing Well Pharmaceutical, 2 Actylis, 3 Gangwal Chemicals, 1 BASF, 1 Jai Radhe Sales, 6 Seppic

REGULATORY FILINGS

6 Suppliers, 6 USDMF, 3 CEP/COS

SOLUTIONS BY APPLICATIONS

10 Solubilizers, 5 Parenteral, 3 Emulsifying Agents, 3 Topical, 2 Surfactant & Foaming Agents, 1 Co-Processed Excipients, 1 Film Formers & Plasticizers, 1 Direct Compression, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

ANALYTICAL SOLUTION(s)

1 Other Ref. Standards

1 Other Ref. Standards

FINISHED FORMULATIONS

571 ORAL, 352 TABLET, 59 INJECTABLE, 53 TABLET, EXTENDED RELEASE, 52 INJECTION, 36 SUSPENSION, 35 CAPSULE, 31 CAPSULE, DELAYED REL PELLETS, 19 NASAL, 19 SPRAY, METERED, 19 TOPICAL, 18 OPHTHALMIC, 15 TABLET, DELAYED RELEASE, 13 CAPSULE, DELAYED RELEASE, 13 FOR SUSPENSION, 12 CAPSULE, EXTENDED RELEASE, 12 CREAM, 12 SUSPENSION/DROPS, 10 SOLUTION/DROPS, 9 GEL, 9 INHALATION, 8 SUSPENSION, EXTENDED RELEASE, 7 INTRAVENOUS, 7 POWDER, 7 VAGINAL, 6 ORAL-28, 6 SOLUTION, 5 RECTAL, 5 SUPPOSITORY, 4 BUCCAL, 4 GUM, CHEWING, 3 GRANULE, 3 INTRAMUSCULAR, 3 OTIC, 2 CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS, 2 EMULSION, 2 FOR SUSPENSION, DELAYED RELEASE, 2 IV (INFUSION), 2 LOTION, 2 ORAL-21, 2 TABLET, CHEWABLE, 2 TABLET, ORALLY DISINTEGRATING, 2 VIAL, 1 AEROSOL, FOAM, 1 ENEMA, 1 FOR SOLUTION, 1 FOR SUSPENSION, EXTENDED RELEASE, 1 INJECTABLE, TABLET, 1 INTRA-ARTICULAR, 1 INTRAMUSCULAR, ORAL, 1 INTRAVENOUS, ORAL, 1 OPHTHALMIC, OTIC, 1 POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER, 1 SUBCUTANEOUS, 1 SUBCUTANEOUS LYOPHILIZED POWER, 1 SYRINGE, 1 SYRUP, 1 SYSTEM